Preliminary PILOTE Study of cyproterone acetate for the treatment of aggressive behavior associated with severe dementia;Étude pilote préliminaire de l'acétate de cyprotérone dans les comportements agressifs associés aux démences sévères

Revue Neurologique

Volumn 161, Issue 11, 2005, Pages 1071-1078

  Caparros Lefebvre, D ^a,c   Dewailly, D ^b  

^a CENTRE HOSPITALIER DE VALENCIENNES   (France)

^b LILLE UNIVERSITY HOSPITAL   (France)

^c NONE   (France)

Author keywords

Aggressive behavior; Alzheimer's disease; Antiandrogen; Cyproterone; Vascular dementia

Indexed keywords

ALPRAZOLAM; CYPROTERONE ACETATE; HALOPERIDOL; LEVOMEPROMAZINE; MEPROBAMATE; MIANSERIN; OLANZAPINE; PSYCHOTROPIC AGENT; RISPERIDONE; ANTIANDROGEN; CYPROTERONE; NEUROLEPTIC AGENT;

AGED; AGGRESSION; AGITATION; ALZHEIMER DISEASE; ARTICLE; BEHAVIOR; BEHAVIOR DISORDER; CLINICAL ARTICLE; CLINICAL ASSESSMENT; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DAILY LIFE ACTIVITY; DEMENTIA; DIFFUSE LEWY BODY DISEASE; DISEASE SEVERITY; EVOLUTIONARY ADAPTATION; FEMALE; HUMAN; HUNTINGTON CHOREA; IMPULSIVENESS; MALE; MENTAL HEALTH; MOTOR DYSFUNCTION; MULTIINFARCT DEMENTIA; PILOT STUDY; RATING SCALE; STATISTICAL SIGNIFICANCE; TREATMENT OUTCOME; TREATMENT WITHDRAWAL; DRUG ADMINISTRATION; HOSPITALIZATION; PSYCHOLOGICAL ASPECT; RESTLESSNESS;

AGED; AGGRESSION; ALZHEIMER DISEASE; ANDROGEN ANTAGONISTS; ANTIPSYCHOTIC AGENTS; CYPROTERONE; DEMENTIA; DEMENTIA, VASCULAR; DRUG ADMINISTRATION SCHEDULE; FEMALE; HUMANS; HUNTINGTON DISEASE; IMPULSIVE BEHAVIOR; MALE; PILOT PROJECTS; PSYCHOMOTOR AGITATION; SEVERITY OF ILLNESS INDEX;

EID: 29444445633     PISSN: 00353787     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0035-3787(05)85174-4     Document Type: Article

References (50)

1. AD 2000 COLLABORATIVE GROUP. (2004). Long-term donezepil treatment in 565 patients with Alzheimer's disease (AD2000): randomised double-blind trial. Lancet, 363: 2105-2115.
2. ALBERT DJ, WALSH ML, JONIK RH. (1993). Aggression in humans: what is its biological foundation? Neurosci Biobehav Rev, 17: 405-425.
3. AMADEO M. (1996). Antiandrogen treatment of aggressivity in men suffering from dementia. J Geriatr Psychiatry Neurol, 9: 142-145.
4. BRADFORD JMW, MC LEAN D. (1984). Sexual offenders, violence and testosterone: a clinical study. Can J Psychiatry, 29: 335-343.
5. BRIKEN P, NIKA E, BERNER W. (2001). Treatment of paraphilia with luteinizing hormone-releasing hormone agonists. J Sex Marital Ther, 27: 45-55.
6. BRONSKILL SE, ANDERSON GM, SYKORA K et al. (2004). Neuroleptic drug theray in older adults newly admitted to nursing homes: incidence, dose, and specialist contact. J Am Geriatr Soc, 52: 749-755.
7. BROWN WA, DAVIS GH. (1975). Serum testosterone and irritability in man. Psychosom Med, 137: 87.
8. BYERLY MJ, WEBER MT, BROOKS DL, SNOW LR, WORLEY MA, LESCOUFLAIR E. (2001). Antipsychotic medications and the elderly: effects on cognition and implications for use. Drus aging, 18: 45-61.
9. CARLYLE W, KILLICK L, ANCILL R. (1991). ECT: an effective treatment in the screaming demented patient. J Am Geriatr Soc, 39: 637.
10. CLANCY AN, BONSALL RW, MICHAEL RP. (1992). Imunohistochemical labelling of androgen receptors in the brain of rat and monkey. Life Sci, 50: 409-417.
11. COHEN-MANSFIELD J. (1996). Conceptualization of agitation: results based on the Cohen-Mansfield agitation inventory and the agitation behavior mapping instrument. Int Psychogeriatr, 8 (suppl 3): 309-315.
12. CONACHER GN, WORKMAN DG. (1989). Violent crime possibly associated with anabolic steroid use. Am J Psychiatr, 146: 679.
13. COOPER AJ. (1987). Medroxyprogesterone acetate (MPA) treatment of sexual acting out in men suffering from dementia. J Clin Psychiatry, 9: 368-370.
14. COOPER JK, MUNGAS D, WEILER PG. (1990). Relation of cognitive status and abnormal behaviors in Alzheimer's disease. J Am Geriatr Soc, 38: 867-870.
15. CUMMINGS JL, GRAY K, ROSENBERG-THOMPSON S, CARUSI DA, GORNBEIN J. (1994). The neuropsychiatric inventory: comprehensive assessment of psychopathology in dementia. Neurology, 44: 2308-2314.
16. EATON GG, WORLEIN JM, KELLEY ST, VIJAYARAGHAVAN S, HESS DL, AXTHELM MK, BETHEA CL. (1999). Self-injurious behaviour is decreased by cyproterone acetate in adult male rhesus (Macaca mulatta). Horm Behav, 35: 195-203.
17. EISDORFER C, COHEN D, PAVEZA GJ et al. (1992). An empirical evaluation of the Global Deterioration Scale for staging Alzheimer's disease. Am J Psychiatry, 149: 190-194.
18. ELLINGROD VL, SCHULTZ SK, EKSTAM-SMITH K, KUTSCHER E, TURVEY C, ARNDT S. (2002). Comparison of risperidone with olanzapine in elderly patients with dementia and psychosis. Pharmacotherapy, 22: 1-5.
19. GREEN HJ, PAKENHAM KI, HEADLEY BC et al. (2002). Altered cognitive function in men treated for prostate cancer with luteinizing hormone-releasing hormone analogues and cyproterone acetate: a randomized controlled trial. BJU, 90: 427-432.
20. GREEN HJ, PAKENHAM KI, HEADLEY BC et al. (2004). Quality of life during pharmacological treatments and clinical monitoring for non-localized prostate cancer: a randomized controlled trial. BJU, 93: 975-979.
21. GUTIERREZ M, MENENDEZ L, RUIZ-GAYO M, HIDALGO A, BAAMONDE A. (1997). Cyproterone acetate displaces opiate binding in mouse brain. Eur J Pharmacol, 328: 99-102.
22. HAU M, WIKELSKI M, SOMA KK, WINGFIELD JC. (2000). Testosterone and year-round territorial aggression in a tropical bird. Gen Comp Endocrinol, 117: 20-33.
23. HAUSSERMANN P, GOECKER D, BEIER K, SCHROEDER S. (2003). Low-dose cyproterone acetate treatment of sexual acting out men with dementia. Int Psychogeriatr, 15: 181-186.
24. HOPE T, KEEN J, GEDLING K, COOPER S, FAIRBURN C, JACOBY R. (1997). Behaviour changes in dementia. Int J Geriatr Psychiatry, 12: 1062-1073.
25. KOSS E, WEINER M, ERNESTO C et al. (1997). Assessing patterns of agitation in Alzheimer's disease patients with the Cohen-Mansfield agitation inventory. The Alzheimer's Disease cooperative study. Alzheimer Dis Assoc Disord, 11 (Suppl 2): S45-S50.
26. KREUTZ LE, ROSE RM. (1972). Assessment of aggressive behavior and plasma testosterone in a young criminal population. Psychosom Med, 34: 321-332.
27. KYOMEN HH, NOBEL KW, WEI JY. (1991). The use of estrogen to decrease aggressive physical behavior in elderly men with dementia. J Am Geriatr Soc, 39: 1110-1112.
28. KYOMEN HH, SATLIN A, WIE JY et al. (1997). Estrogen therapy decreases physically aggressive behaviors in elderly long-term care facility dementia patients: results from a double-blind, placebo-controlled clinical trial. J Neuropsychiatry Clin Neurosci, 9: 174.
29. LEGER JM, MOULIAS R, VELLAS B et al. (2000). Causes et conséquences de l'agitation et des comportements agressifs du sujet âgé. Encéphale, 26: 32-43.
30. MATTE AC, FABIAN E. (1978). The effect of cyproterone acetate on motor activity, aggression, emotionality, body weight and testes in wild mice. Andrologia, 10: 155-162.
31. MATTSON A, SCHALLING D, OLWEUS D, LOW H, SVENSSON L. (1980). Plasma testosterone, aggressive behaviour and personnality dimensions in young male delinquants. J Am Acad Child Psychiatry, 19: 476-490.
32. MC SHANE R, KEENE J, GEDLING K, FAIRBURN C, JACOBY R, HOPE T. (1997). Do neuroleptic drugs hasten cognitive decline in dementia? Prospective study with necropsy follow-up. BMJ, 314: 266-270.
33. MEGA MS, CUMMINGS JL, FIORELLO T et al. (1996). The spectrum of behavioral changes in Alzheimer's disease. Neurology, 46: 130-135.
34. MINAIRE P. (1999). La mesure de l'indépendance fonctionnelle (MIF) : historique, présentation, perspectives. J Réadapt Méd, 11: 168-174.
35. OTT BR, LAPANE KL, GAMBASSI G. (2000). Gender differences in the treatment of behaviour problems in Alzheimer's disease. SAGE study group. Systemic Assessment of Geriatric drug use via Epidemiology. Neurology, 54: 427-432.
36. PANCRAZI MP, METAIS P. (2003). Delirious states in elderly persons. Therapeutic modalities. Presse Med, 32: 750-755.
37. PERSKY H, SMITH KD, BASU GK. (1971). Relation of psychological measures of aggression and hostility to testosterone production in man. Psychosom Med, 33: 265-277.
38. PRASAD V, SHEARD MH. (1981). The effect of cyproterone acetate on shock elicited aggression in rats. Pharmacol Biochem Behav, 15: 691-694.
39. RAMAROSON H, HELMER C, BARBERGER-GATEAU P et al. (2003). Prévalence de la démence et de la maladie d'Alzheimer chez les personnes de 75 ans et plus : données réactualisées de la cohorte PAQUID. Rev Neurol (Paris), 159: 405-411.
40. RUBINOW DR, SCHMIDT PJ. (1996). Androgens, brain and behavior. Am J Psychiatry, 153: 974-984.
41. SALMINEN E, PORTIN R, KORPELA J, BACKMAN H, PARVINEN LM, HELENIUS H, NURMI M. (2003). Androgen deprivation and cognition in prostate cancer. Br J Cancer, 89: 971-976.
42. SAR M, LUBAHN DB, FRENCH FS, WILSON EM. (1990). Immunohistochemical localization of the androgen receptor in rat and human tissues. Endocrinology, 127: 3180-3186.
43. SARRIEAU A, MITCHELL JB, LAL S, OLIVIER A, QUIRION R, MEANEY MJ. (1990). Androgen binding sites in human temporal cortex. Neuroendocrinology, 51: 713-716.
44. SCARAMELLA T, BROWN WA. (1978). Serum testosterone and aggressiveness in hockey players. Psychosom Med, 42: 253-296.
45. SHELTON PS, BROOKS VG. (1999). Estrogen for dementia-related aggression in elderly men. Ann Pharmacother, 33: 808-812.
46. SLABBEKOORN D, VAN GOOZEN SH, MEGENS J, GOOREN LJ, COHEN-KETTENIS PT. (1999). Activating effects of cross-sex hormones on cognitive functions: a study of short-term and long-term hormone effects in transsexuals. Psychoneuroendocrinology, 24: 423-447.
47. THIBAUT F, KUHN JM, CORDIER B, PETIT M. (1998). Hormone treatment in sex offenses. Encéphale, 24: 132-137.
48. VAN KEMENADE JF, COHEN-KETTENIS PT, COHEN L, GOOREN LJ. (1989). Effects of the pure antiandrogen RU 23.903 (anandron) on sexuality, aggression and mood in male-to-female transsexuals. Arch Sex Behav, 18: 217-228.
49. ZARIT SH, ORR NK, ZARIT JM. (1985). The hidden victims of Alzheimer's disease. New York University Press. New York.
50. ZARIT SH, TERI L. (1991). Interventions and services for family caregivers. Annu Rev Gerontol Geriatr, 11: 241-265.